Updated report on identification of molecular predictors of tazemetostat response in an ongoing NHL phase 2 study
Authors
McDonald, AThomas, E
Daigle, S
Morschhauser, F
Salles, G
Ribrag, V
Mckay, P
Tilly, H
Schmitt, A
Batlevi, CL
Fruchart, C
Johnson, P
Dickinson, M
Opat, S
Jurczak, W
Cartron, G
Lamy, T
Zinzani, L
Assouline, S
Radford, John A
Gribben, G
Haioun, C
Chaidos, A
Le Gouill, S
Clawson, A
Larus, J
Blakemore, J
Affiliation
The Christie NHS Foundation Trust, ManchesterIssue Date
2018
Metadata
Show full item recordCitation
McDonald A, Thomas E, Daigle S, Morschhauser F, Salles G, Ribrag V, et al.Updated report on identification of molecular predictors of tazemetostat response in an ongoing NHL phase 2 study. Blood. 2018;132.Journal
BloodDOI
10.1182/blood-2018-99-115132Additional Links
https://dx.doi.org/10.1182/blood-2018-99-115132Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1182/blood-2018-99-115132